Valery Moine
Plan, GR 1228, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A third-generation, high-affinity biparatopic anti-tau antibody inhibits intracellular tau aggregation seeded by Alzheimer's brain extracts.
Journal: Alzheimer's research & therapy
Published: May 19, 2026
NI-3201 Is a Bispecific Antibody Mediating PD-L1-Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control.
Journal: Cancer immunology research
Published: March 28, 2024
Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody.
Journal: Frontiers in immunology
Published: January 30, 2024
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
Journal: Journal of hematology & oncology
Published: October 19, 2023
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model.
Journal: Experimental hematology & oncology
Published: January 21, 2022
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity.
Journal: Antibodies (Basel, Switzerland)
Published: October 30, 2017
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 05, 2016
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG.
Journal: Nature communications
Published: November 12, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026